Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

bioAffinity Technologies, Inc. (BIAF)

NASDAQ

$5.16

$-0.15

(-2.89%)

bioAffinity Technologies, Inc. (BIAF) Live Price Chart

Last updated: ⁦2026-08-26 15:24:00⁩. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$3.14M
Open	$5.19
High	$6,997.50
Low	$4.88
Previous Close	$5.19
Price Change	$-0.15
Percentage Change	-2.89%
Volume	39K

bioAffinity Technologies, Inc. (BIAF) Stock Price Today

bioAffinity Technologies, Inc. (BIAF) is currently trading at $5.16 as of 2026-08-26 15:22:00, reflecting a -2.89% move ($-0.15) from the previous close.

In the short term, the stock has returned -45.26% over the past four weeks. Over the last 12 months, bioAffinity Technologies, Inc. has recorded a -95.45% price change, indicating a Weak performance relative to the broader market.

bioAffinity Technologies, Inc. (BIAF) 7-Day Stock Price Changes

Over the past seven days, bioAffinity Technologies, Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. During this period, the stock moved from its previous closing price of $5.79 to the latest recorded price of $5.16, reflecting an intraday change of -2.89%. Daily movements highlight shifts in trading volume (38,845), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BIAF has delivered a -45.26% return over the past month and a -95.45% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy bioAffinity Technologies, Inc. (BIAF)

You can buy and trade BIAF on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for BIAF and Execute Your Trade

Open the trading page, enter BIAF in the search bar, select the amount of BIAF you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is bioAffinity Technologies, Inc. (BIAF)?

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

bioAffinity Technologies, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	57
Sector	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Website	https://www.bioaffinitytech.com

Frequently Asked Questions (FAQ)

1.Can I buy and sell U.S. stocks directly on MEXC right now?

Yes. MEXC supports direct trading of U.S. stocks in three ways: RealStocks (held via a regulated broker partner), Tokenized Stocks that trade 24/7 with self-custody, and Stock Futures with up to 200x leverage. You can fund a purchase with local currency or crypto, and manage all three product types from a single account.

2.What type of U.S. stocks can I trade on MEXC?

You can trade thousands of leading U.S. equities listed on major exchanges like the NYSE and NASDAQ, including tech giants like Apple (AAPL), Tesla (TSLA), and NVIDIA (NVDA), as well as newly listed IPOs. Availability varies by product type — RealStocks, Tokenized Stocks, and Stock Futures each carry their own list of supported tickers.

3.Are stock prices and trading data updated in real-time?

Yes. MEXC provides real-time pricing, 24-hour fluctuations, and market cap rankings across all three stock products, so your buy and sell decisions are based on live data, not delayed quotes.

4.Can I trade U.S. stocks 24/7, or only during market hours?

It depends on the product. RealStocks follow standard U.S. market hours (9:30 AM–4:00 PM ET, Monday–Friday). Tokenized Stocks and Stock Futures trade continuously, 24/7, letting you act on price moves even when traditional markets are closed.

5.Does MEXC charge commission on U.S. stock trading?

RealStocks trade commission-free. Tokenized Stocks and Stock Futures carry a small trading fee, among the lowest in the industry — currently as low as 0.00%/0.02% maker/taker on Stock Futures.

6.What does BIAF's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -28.11 summarises how much profit bioAffinity Technologies, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track bioAffinity Technologies, Inc.'s financial performance over time?

To follow bioAffinity Technologies, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BIAF is performing and how the market is responding.

8.When is bioAffinity Technologies, Inc. expected to report earnings?

bioAffinity Technologies, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BIAF, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in bioAffinity Technologies, Inc.'s earnings reports?

bioAffinity Technologies, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BIAF is meeting, beating or missing expectations.

10.How can I stay informed about bioAffinity Technologies, Inc.'s results and guidance?

You can stay up to date on bioAffinity Technologies, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BIAF on this page helps you see how new information is being reflected in the stock.

11.Does bioAffinity Technologies, Inc. pay a regular cash dividend to its shareholders?

bioAffinity Technologies, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BIAF's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for BIAF?

Based on the latest earnings data, BIAF has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether bioAffinity Technologies, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings bioAffinity Technologies, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is bioAffinity Technologies, Inc.?

bioAffinity Technologies, Inc. is a publicly traded company in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is BIAF valued in terms of P/E ratio and EPS?

bioAffinity Technologies, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -28.11. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of bioAffinity Technologies, Inc.'s earnings. Comparing BIAF's P/E and EPS to those of other SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

MDT

ACN

NOW

BMO

Top Gainers

Browse today's leading gainers in the US stock market

Cre8 Enterprise Limited

CRE

Expion360 Inc.

XPON

YY Group Holding Limited

YYGH

Ohmyhome Limited

OMH

Abercrombie & Fitch Co.

ANF

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

BIAF-to-USD Calculator

Amount

BIAF

USD

1 BIAF = 5.16 USD